These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2654037)
21. [Neurotransmitters in anxiety and panic disorders]. Ackenheil M Psychiatr Prax; 1990 Jan; 17(1):23-8. PubMed ID: 1969168 [TBL] [Abstract][Full Text] [Related]
22. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. Esler M; Alvarenga M; Pier C; Richards J; El-Osta A; Barton D; Haikerwal D; Kaye D; Schlaich M; Guo L; Jennings G; Socratous F; Lambert G J Psychopharmacol; 2006 Jul; 20(4 Suppl):60-6. PubMed ID: 16785272 [TBL] [Abstract][Full Text] [Related]
23. Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder. Gold PW; Pigott TA; Kling MA; Kalogeras K; Chrousos GP Psychiatr Clin North Am; 1988 Jun; 11(2):327-34. PubMed ID: 3047702 [TBL] [Abstract][Full Text] [Related]
24. Use of serotonergic agents in the clinical assessment of central serotonin function. Murphy DL; Mueller EA; Garrick NA; Aulakh CS J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586 [TBL] [Abstract][Full Text] [Related]
27. Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment. Charney DS; Heninger GR Arch Gen Psychiatry; 1986 Nov; 43(11):1059-65. PubMed ID: 3767596 [TBL] [Abstract][Full Text] [Related]
29. Serotonergic responsivity in eating disorders. McBride PA; Anderson GM; Khait VD; Sunday SR; Halmi KA Psychopharmacol Bull; 1991; 27(3):365-72. PubMed ID: 1775611 [TBL] [Abstract][Full Text] [Related]
30. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Den Boer JA; Westenberg HG Psychopharmacology (Berl); 1990; 102(1):85-94. PubMed ID: 1697419 [TBL] [Abstract][Full Text] [Related]
31. Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls. Westenberg HG; den Boer JA Psychopharmacology (Berl); 1989; 98(2):283-5. PubMed ID: 2526957 [TBL] [Abstract][Full Text] [Related]
37. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Kahn RS; Wetzler S; van Praag HM; Asnis GM; Strauman T Psychiatry Res; 1988 Jul; 25(1):101-4. PubMed ID: 3217461 [TBL] [Abstract][Full Text] [Related]
38. The Galway Study of Panic Disorder. II: Changes in some peripheral markers of noradrenergic and serotonergic function in DSM III-R panic disorder. Butler J; O'Halloran A; Leonard BE J Affect Disord; 1992 Oct; 26(2):89-99. PubMed ID: 1447432 [TBL] [Abstract][Full Text] [Related]
39. High-affinity platelet [3H]LSD binding is decreased in panic disorder. Norman TR; Judd FK; Staikos V; Burrows GD; McIntyre IM J Affect Disord; 1990 Jun; 19(2):119-23. PubMed ID: 2142698 [TBL] [Abstract][Full Text] [Related]
40. Serotonin in panic disorder: platelet uptake and concentration. McIntyre IM; Judd FK; Burrows GD; Norman TR Int Clin Psychopharmacol; 1989 Jan; 4(1):1-6. PubMed ID: 2592755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]